Designing appropriate clinical trials to assess ACEI use and cognitive decline in older adults with hypertension.
Todd
Stephen
S
McGuinness
Bernadette
B
Passmore
A Peter
AP
D000203:Activities of Daily Living; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001812:Blood-Brain Barrier / Q000502:physiology; D003071:Cognition / Q000187:drug effects*; D003704:Dementia / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D018450:Disease Progression; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D015994:Incidence; D008297:Male
D000806:Angiotensin-Converting Enzyme Inhibitors